Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HELIOS UNDERWRITING PLC Director's Dealing 2025

Apr 9, 2025

7691_pos_2025-04-09_02d1d875-ea17-48ef-a5fc-7240145e468a.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3449E

Helios Underwriting Plc

09 April 2025

9 April 2025

Helios Underwriting plc

("Helios" or the "Company")

Director's Shareholding

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, was informed on 8 April 2025 that Mr Nigel Hanbury, Non-Executive Deputy Chairman and Director of the Company and persons closely associated with Mr Hanbury, on the same day, sold 41,400 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 193 pence per share and subsequently purchased 41,400 Ordinary Shares at a price of 193.07 pence per share. Mr Hanbury's total interest remains unchanged at 9,494,725 Ordinary Shares, representing 13.11% of the issued share capital of the Company.

The notifications below, which has been made in accordance with the requirement of the EU Market Abuse Regulation, provide further details.

For further information, please contact:

Helios Underwriting plc

John Chambers - Executive Chairman                                             44 (0)203 965 6441

Arthur Manners - Chief Financial Officer                                              

Deutsche Numis (Nomad and Broker)                                        

Giles Rolls / Charles Farquhar                                                        +44 (0)20 7260 1000

FTI Consulting 

Ed Berry / Nathan Hambrook-Skinner                                            +44 (0)7703 330 199 / +44 (0)7977 817 092

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £484m of capacity for the 2025 year of account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Hanbury (Director)

George Hanbury (PCA)

Clementine Hanbury (PCA)

Elizabeth Hanbury (PCA)

2

Reason for the notification

a)

Position/status

Director

PCA

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN - GB00B23XLS45

b)

Nature of the transaction

On market sale and purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
Sale: 193p 10,350
Sale: 193p 10,350
Sale: 193p 10,350
Sale: 193p 10,350
Purchase: 193.07p 10,350
Purchase: 193.07p 10,350
Purchase: 193.07p 10,350
Purchase: 193.07p 10,350

d)

Aggregated information

Price(s) Volume(s)
Sale: 193p 41,400
Purchase: 193.07p 41,400

e)

Date of the transaction

8 April 2025

f)

Place of the transaction    

London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFKLFBEZLLBBB